How has President Trump's "America First" philosophy affected US patent policy? White & Case partners discussed what an evolving US patent policy will mean for other nations, and to propose effective responses....more
7/26/2019
/ Broadest Reasonable Interpretation Standard ,
Claim Amendments ,
Claim Construction ,
Diagnostic Method ,
International Summits ,
Japan ,
Life Sciences ,
Patent Trial and Appeal Board ,
Patent Trolls ,
Patent-Eligible Subject Matter ,
Patents ,
Post-Grant Review ,
Presidential Appointments ,
Treatment Method Patents ,
Trump Administration ,
United States ,
USPTO
A divided Supreme Court changed the landscape of administrative law in a recent decision, Kisor v. Wilkie. In Kisor, a slim majority declined to overrule Bowles v. Seminole Rock & Sand Co., Auer v. Robbins and related cases,...more
7/18/2019
/ Administrative Agencies ,
Ambiguous ,
Appeals ,
Auer Deference ,
Kisor v Wilkie ,
Patent Litigation ,
Patents ,
Reasonable Interpretations ,
Remand ,
SCOTUS ,
Stare Decisis ,
USPTO ,
Vacated ,
Veterans' Benefits
In July 2015, the Court of Justice of the European Union ("ECJ") issued Huawei v. ZTE, a seminal decision detailing how holders of Standard Essential Patents ("SEPs") must license its SEPs on fair, reasonable, and...more
5/28/2019
/ Antitrust Violations ,
Appeals ,
EU ,
European Court of Justice (ECJ) ,
FRAND ,
Huawei ,
Injunctive Relief ,
IP License ,
Market Abuse ,
Netherlands ,
Patent Infringement ,
Patents ,
Standard Essential Patents
Squib of Holding and Key Implication:
The United States Supreme Court, in Helsinn Healthcare S.A. v. Teva Pharmaceuticals USA, Inc., held on January 22, 2019 that "a commercial sale to a third party who is required to keep...more
2/6/2019
/ America Invents Act ,
Amicus Briefs ,
Appeals ,
Assignment of Inventions ,
Confidentiality Agreements ,
Generic Drugs ,
Helsinn Healthcare SA v Teva Pharmaceuticals USA Inc ,
Inventions ,
Manual of Patent Examining Procedure (MPEP) ,
On-Sale Bar ,
Patent Infringement ,
Patents ,
Pharmaceutical Patents ,
Printed Publications ,
Prior Art ,
SCOTUS ,
Solicitor General ,
Teva Pharmaceuticals ,
Third-Party Relationships